HC Wainwright reissued their buy rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a report issued on Tuesday morning, Benzinga reports. The brokerage currently has a $17.50 target price on the biopharmaceutical company’s stock. A number of other research firms also recently commented on VSTM. Royal Bank of Canada reaffirmed an outperform rating […]
Verastem (NASDAQ:VSTM – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $17.50 price objective on the biopharmaceutical company’s stock. HC Wainwright’s target price would suggest a potential upside of 337.50% from the company’s […]
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given an average recommendation of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have issued a report on the stock in the […]
Verastem, Inc (NASDAQ:VSTM) Receives Average Recommendation of Buy from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reiterated their buy rating on shares of Verastem (NASDAQ:VSTM – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $17.50 target price on the biopharmaceutical company’s stock. VSTM has been the subject of several other research reports. BTIG Research restated a buy rating […]